Janux Therapeutics
The Executive Director, Process Development & Manufacturing provides strategic and technical leadership for cell line, cell culture, and downstream process development for drug substance manufacturing. This role oversees the progression from research and preclinical development through clinical stages and commercialization, ensuring robust, scalable, and phase-appropriate manufacturing processes. The position involves leading process characterization, technology transfer, and manufacturing readiness while collaborating with cross-functional teams to support global regulatory expectations.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2017
Janux Therapeutics is a biotechnology company developing precision‑engineered T cell immunotherapies. They design novel therapeutics that selectively modulate T cells to treat cancer and autoimmune diseases while minimizing systemic safety issues. Their approach focuses on targeted modulation of immune responses to improve efficacy and reduce toxicity. Janux aims to translate selective T‑cell control into safer, more effective immunotherapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Janux Therapeutics.
74% above the average for this role
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
1 month ago
Senior Scientist, Engineering- Cell Banking
MSD
Biologics Process Development Scientific Lead
MSD
Senior Scientist
AstraZeneca
Scientist, Vaccines and Advanced Biotechnologies (VAX) Process R&D
MSD
Research Scientist, Process Development
Merck & Co., Inc.
Director / Principal Scientist, Biologics Drug Substance Commercialization (BDSC)
MSD